- Home
- ARVN vs IMXI Comparison
ARVN vs IMXI Comparison
Compare ARVN & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- IMXI
- Stock Information
- Founded
- ARVN 2015
- IMXI 1994
- Country
- ARVN United States
- IMXI United States
- Employees
- ARVN N/A
- IMXI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- IMXI Retail: Computer Software & Peripheral Equipment
- Sector
- ARVN Health Care
- IMXI Technology
- Exchange
- ARVN Nasdaq
- IMXI Nasdaq
- Market Cap
- ARVN 456.2M
- IMXI 302.5M
- IPO Year
- ARVN 2018
- IMXI N/A
- Fundamental
- Price
- ARVN $7.77
- IMXI $10.64
- Analyst Decision
- ARVN Buy
- IMXI Buy
- Analyst Count
- ARVN 21
- IMXI 7
- Target Price
- ARVN $20.53
- IMXI $19.60
- AVG Volume (30 Days)
- ARVN 2.1M
- IMXI 331.1K
- Earning Date
- ARVN 07-29-2025
- IMXI 08-06-2025
- Dividend Yield
- ARVN N/A
- IMXI N/A
- EPS Growth
- ARVN N/A
- IMXI 1.60
- EPS
- ARVN N/A
- IMXI 1.70
- Revenue
- ARVN $426,900,000.00
- IMXI $652,547,000.00
- Revenue This Year
- ARVN $4.26
- IMXI N/A
- Revenue Next Year
- ARVN N/A
- IMXI $3.03
- P/E Ratio
- ARVN N/A
- IMXI $5.92
- Revenue Growth
- ARVN 498.74
- IMXI N/A
- 52 Week Low
- ARVN $5.90
- IMXI $9.76
- 52 Week High
- ARVN $34.11
- IMXI $22.38
- Technical
- Relative Strength Index (RSI)
- ARVN 50.16
- IMXI 38.65
- Support Level
- ARVN $7.09
- IMXI $9.76
- Resistance Level
- ARVN $7.89
- IMXI $10.20
- Average True Range (ATR)
- ARVN 0.35
- IMXI 0.34
- MACD
- ARVN 0.00
- IMXI -0.00
- Stochastic Oscillator
- ARVN 38.14
- IMXI 20.25
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.